Laurus Synthesis

Laurus Synthesis company information, Employees & Contact Information

Updated June 2026

Quick answer

Laurus Synthesis is a Pharmaceutical Manufacturing company and founded in 2006. It has approximately 85 employees on record. Contact data was last refreshed in June 2026. Find Laurus Synthesis's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Laurus Synthesis offers world-class contract development and manufacturing services. With strengths in flexi-scale drug substance manufacturing and phase-appropriate chemical and analytical development, Laurus Synthesis is well-positioned to meet all NCE drug substance needs of clients, from preclinical through to commercial manufacture. Innovative, robust and scalable chemistry is the core strength of Laurus Synthesis. We handle developmental candidates for clients at all stages of the drug lifecycle from route identification to custom synthesis and early clinical to commercialization. Our development and manufacturing teams maintain a tight focus on performance at scale, continuous process improvement, securing and de-risking supply chains to provide an efficient, compliant, cost-effective and long-term commercial drug substance solution.

Company Details

Employees
85
Founded
2006
Address
2nd Floor, Serene Chambers, Rd # 7,, Banjara Hills,hyderabad 500034,india
Phone
+91 40 3980 4333
Email
bd****@****abs.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Banjara Hills, Hyderabad
Looking for a particular Laurus Synthesis employee's phone or email?

Laurus Synthesis Questions

News

Laurus Labs announces restructuring plan to dissolve subsidiary Laurus Synthesis - CNBC TV18

Laurus Labs announces restructuring plan to dissolve subsidiary Laurus Synthesis CNBC TV18

FDA follows Form 483 to Indian drugmaker Laurus Synthesis with a 2nd rebuke - Fierce Pharma

FDA follows Form 483 to Indian drugmaker Laurus Synthesis with a 2nd rebuke Fierce Pharma

Top Laurus Synthesis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant